ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced finan…
Author: Business Wire
Bausch + Lomb Announces Third-Quarter 2025 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results. “We’re delivering on the…
Samsung Bioepis to Commercialize BYOOVIZ® (ranibizumab) in Europe from January 2026
INCHEON, Korea–(BUSINESS WIRE)– #BYOOVIZ–Samsung Bioepis Co., Ltd. announced today that the company has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioepis’ two ophthalmology assets: BYOOVIZ® (ranibizumab), a biosimi…
Scott Foster, CPA, MBA, Joins Sightview as Chief Financial Officer
DURHAM, N.C.–(BUSINESS WIRE)–Sightview, the only electronic health record and practice management partner focused solely on eyecare, has appointed D. Scott Foster (Scott), CPA, MBA, as chief financial officer. With more than thirty years of experienc…
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– #AMR–Locus Biosciences announced a research collaboration with Viatris to develop engineered bacteriophage therapies for ophthalmic infections.
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of statis…
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/NYSE: ALC), STAAR’s Special Meeting of Stockholders in…
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today issued the following statement reg…
Sydnexis Receives Complete Response Letter from FDA for SYD-101 to Slow Pediatric Myopia Progression
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis, Inc., (www.sydnexis.com), a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL…
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
GENEVA & LAKE FOREST, Calif.–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), today …
NextGen Healthcare and Eyefinity Align to Expand Offerings for Optometrists and Ophthalmologists
RANCHO CORDOVA, Calif.–(BUSINESS WIRE)– #NextGenHealthcare–NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, today announced the enhancement of its offerings for optometrists and ophthalmologists thro…
Global Healthy Living Foundation Leads Nationwide Recognition of Giant Cell Arteritis Awareness Day on October 23
UPPER NYACK, N.Y.–(BUSINESS WIRE)– #arthritis–Giant Cell Arteritis, an inflammatory blood vessel condition, gets recognition day October 23
Foster Grant Releases New Wicked: For Good – Inspired Eyewear
SMITHFIELD, R.I.–(BUSINESS WIRE)–Foster Grant, one of the world’s leading over-the-counter eyewear brands, has unveiled the second installment of its Wicked x Foster Grant collection, ahead of the upcoming release of Universal Pictures’ epic conclusi…
National Vision Holdings, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025, and will host a conference call…
Viridian Therapeutics Announces Pricing of $251 Million Public Offering of Shares of Common Stock
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced the pricing of …
Viridian Therapeutics Announces Proposed Underwritten Public Offering
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that it has com…
Cade Prize for Inventivity Announces 2025 Winners
GAINESVILLE, Fla.–(BUSINESS WIRE)– #CadePrize–Named after Dr. James Robert Cade, the lead inventor of Gatorade, the Cade Prize for Inventivity celebrates early-stage companies with innovative ideas and commercial potential. On Tuesday, October 14, f…
IntelePeer Introduces SmartAnalytics Starter Pack to Accelerate AI Adoption and Measurably Improve Business and Patient Outcomes
DANIA BEACH, Fla.–(BUSINESS WIRE)–IntelePeer, the trusted leader in AI-powered automation and analytics for customer and patient interactions, today introduced at HLTH 2025 the SmartAnalytics™ Starter Pack. The Pack gives multi-site healthcare organi…
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today iss…
Science Corp.’s PRIMA BCI Implant Restores Functional Central Vision to Patients with Geographic Atrophy Caused By Age-Related Macular Degeneration, a Leading Cause of Blindness, The New England Journal of Medicine Reports
ALAMEDA, Calif.–(BUSINESS WIRE)–The New England Journal of Medicine (NEJM) today published a peer-reviewed original paper with the results of a landmark clinical trial demonstrating the efficacy of Science Corporation’s PRIMA brain-computer interface…